Finance ❯ Investments ❯ Stock Market ❯ Securities

Investor Rights

Vistagen Faces Federal Securities Class Action After Fasedienol Phase 3 Failure

Investors who bought VTGN during the stated period have until March 16, 2026 to seek lead-plaintiff status.

Baxter Investors Urged to Act as Dec. 15 Lead-Plaintiff Deadline Nears in Novum Pump Lawsuits

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

Law Firms Press Synopsys Investors Ahead of Dec. 30 Lead‑Plaintiff Deadline

MoonLake Faces Expanding Securities Suits as Lead-Plaintiff Deadline Nears

Primo Brands Faces Investor Suits Over BlueTriton Integration as Firms Seek Lead Plaintiffs

James Hardie Investors Face Dec. 23 Deadline in U.S. Securities Suit Over Alleged Inventory Misstatements

CarMax Investor Suits Escalate as Amended Filings Extend Class Period to Nov. 5

Primo Brands Investors Pressed to Act as Securities Suits Target BlueTriton Merger Disclosures

Stride Investor Litigation Widens With New Class Action and Fresh Probes

Stride Investors Urged to Seek Lead Role in Securities Case Before January 12

Stride Faces Federal Securities Class Action Over Enrollment and Compliance Allegations

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

Freeport Faces Investor Class Action Over Grasberg Safety Disclosures as Firms Court Lead Plaintiff

Synopsys Investors Face Dec. 30 Deadline to Seek Lead Role in Securities Class Action Over Design IP Disclosures

Multiple Firms File Securities Class Actions Against Telix in Indiana Federal Court Over Prostate Cancer Program Disclosures

Cytokinetics Faces Wave of Investor Lawsuits as Lead Plaintiff Deadline Nears

DexCom Faces Wave of Securities Class Actions Over FDA-Faulted CGM Changes

KBR Investors Face Nov. 18 Deadline to Seek Lead Role in Securities Suit Over HomeSafe Disclosures

Fiserv Faces Securities Class Action After Q3 Earnings Shock and Outlook Cut